Furthermore, LYP may dephosphorylate other BCR-ABL1 substrates such as CBL, CRKL, and ERK1/2, suggesting that it may play an important role in CML. Here, PTPN22 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.